MA
ACH

Montag & Associates’s Accendra Health ACH Stock Holding History

Montag & Associates’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-750
Closed -$18K – 978
2022
Q3 		$18K Buy
+750
New +$23.1K ﹤0.01% 672

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Montag & Associates's ACH Position: Q4 2022 in Review

Montag & Associates sold out of Accendra Health (ACH) in Q4 2022, closing a stake of 750 shares — an estimated $18K sold.

Montag & Associates first reported a position in ACH in Q3 2022 and held it in 1 quarter. The position peaked at $18K in Q3 2022. 219 funds tracked by Wall St. Rank hold ACH as of Q4 2022.

  • Montag & Associates reported no remaining Accendra Health position as of Q4 2022 after selling out during the quarter.
  • Montag & Associates sold 750 Accendra Health shares in Q4 2022, an estimated $18K.
  • Montag & Associates first reported a position in Accendra Health in Q3 2022 and held it in 1 quarter.
  • Montag & Associates's Accendra Health position peaked at $18K in Q3 2022.
  • 219 funds tracked by Wall St. Rank held Accendra Health as of Q4 2022.

Based on Montag & Associates's 13F filing for Q4 2022, filed 2 Feb 2023.